国新健康：2025年上半年归属股东净亏损9909万元，亏损幅度扩大丨财面儿

Core Insights - The company reported a revenue of 95.53 million, representing a year-on-year decline of 30.47% [1] - The net loss attributable to shareholders was 99.09 million, an increase from a loss of 72.98 million in the same period last year [1] Revenue Breakdown - By Industry: - Service industry revenue was 95.53 million with a gross margin of -15.20%, down 30% year-on-year [2] - By Product: - Digital Medical Insurance: Revenue of 49.70 million, cost of 61.76 million, gross margin of -24.26%, down 6% year-on-year [2] - Digital Healthcare: Revenue of 16.91 million, cost of 18.99 million, gross margin of -12.28%, down 64% year-on-year [2] - Digital Pharmaceuticals: Revenue of 25.00 million, cost of 23.51 million, gross margin of 5.96%, up 80% year-on-year [2] - Health Services: Revenue of 3.83 million, cost of 5.77 million, gross margin of -50.58%, down 82% year-on-year [2] Strategic Focus - The company is driven by a strategy of "Three Medical Collaborations, Innovation-Driven, Digital Ecosystem," focusing on the informatization, digitalization, and intelligence of the healthcare industry [2] - The main business segments include Digital Medical Insurance, Digital Healthcare, Digital Pharmaceuticals, and Health Services, with an emphasis on the value of health big data [2]